Reduced-dose nonvitamin K antagonist oral anticoagulants (NOACs) are commonly
prescribed to Asian patients with nonvalvular atrial fibrillation (NVAF). We aimed to compare …

Background Although randomized trials provide a high level of evidence regarding the
efficacy of non-vitamin K oral anticoagulants (NOACs), the results of such trials may differ …

Background: Limited data regarding efficacy, safety, and optimal dose of nonvitamin K
antagonist oral anticoagulants (NOAC) in Asian patients with nonvalvular atrial fibrillation …

Background To compare the risk of stroke/systemic embolism (S/SE) and major bleeding
(MB) between non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial …

Background and Purpose—Limited data are available describing the relative effectiveness,
safety, and optimal dosing of non–vitamin K antagonist oral anticoagulants (NOACs) for …

Objective To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of
stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants …

Background Off-label dosing non–vitamin K antagonist oral anticoagulants (NOACs) are
commonly prescribed for Asian patients with atrial fibrillation (AF). Objective The purpose of …

Background and Purpose—There are limited real-world data comparing the effectiveness
and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in Asians …

With safety concerns about increasing bleeding, off-label underdosing of non-vitamin K
antagonist anticoagulants (NOACs) is common in East Asian patients with atrial fibrillation …

We performed this meta-analysis to compare the efficacy and safety of reduced-dose non-
vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial …